For drug registration in China, required documentation includes a comprehensive dossier with clinical trial data, quality control standards, manufacturing processes, stability studies, pharmacological and toxicological reports, and proof of Good Manufacturing Practice (GMP) compliance. Additionally, a Certificate of Pharmaceutical Product (CPP) and local agent authorization are necessary.
